5-MeO-DPT
Aliases: O-me-dips, O-methyl-n,n-dipropylserotonin, 5meodpt
Summary
5-MeO-DPT is a Schedule I controlled substance in the United States as a positional isomer of 5-MeO-DiPT, and is also controlled in many other jurisdictions. Its psychedelic effects are described as ambiguous and physically uncomfortable by most users, with minimal visual component and strong auditory distortions. Set and setting are critical; avoid operating vehicles or machinery.
Perspectives
“I typically do not find myself drawn to the 5-MeO tryptamines, though they have plenty of merit. I came into this experience expecting a burdensome trial but was pleasantly surprised by both the gentleness and emotional depth this compound presented.”
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | 3mg | 3-5mg | 5-10mg | 10mg+ |
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset | Total |
|---|---|---|---|---|---|
| Oral | 20-60 min | 30-60 min | 1-2 hrs | 1-2 hrs | 2.8-6 hrs |
Effect Profile
8 reportsScores (1–10) curated from multiple sources:
- Effect keyword matching from PsychonautWiki catalog
- Weighted by importance: core (×3), major (×2), minor (×1)
Moderate visuals with mild headspace and auditory effects, low body load
Tolerance
Tolerance Decay
Pattern inferred from broader serotonergic psychedelic use: noticeable tolerance if reβused within 24β72 h; ~1β2 weeks commonly restores much of sensitivity; 2β3 weeks usually returns to baseline. Data quality: anecdotal/community consensus rather than controlled studies.
Cross-Tolerances
Effects
Aggregated from 8 Erowid experience reports